The future of 23andMe, a genetic testing company, is uncertain due to financial challenges and recent workforce reductions.

Me, the popular at-home genetic testing company, has helped millions of people uncover their family roots and health risks through DNA analysis. Experts fear as the company faces financial issues they ...

In the year since its devastating hack, 23andMe has lost all of its value and most of its governing board — and somehow, ...

The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.” ...

In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...

Me announces 40% workforce reduction and cancellation of therapeutic programs following year of security breaches and ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

We remain deeply grateful to the patients, investigators and study staff for their participation in our clinical trials,” ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...